Tsudoi Miyoshi
Corporate Officer/Principal chez Takeda Pharmaceuticals International, Inc.
Provenance du réseau au premier degré de Tsudoi Miyoshi
Entité | Type d'entité | Industrie | |
---|---|---|---|
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tsudoi Miyoshi via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
University of California | College/University | Corporate Officer/Principal Doctorate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | President Chief Executive Officer | |
Stanford University | College/University | Graduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
The Rockefeller University | College/University | Doctorate Degree | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
CYBERDYNE INC. | Medical Specialties | Chief Operating Officer | |
NISSIN FOODS HOLDINGS CO.,LTD. | Food: Specialty/Candy | Corporate Officer/Principal | |
Nissin Foods GmbH
Nissin Foods GmbH Food: Major DiversifiedConsumer Non-Durables Nissin Foods GmbH manufactures instant noodle products. It offers cup noodles, soba, and ramen. The company was founded in 1993 and is headquartered in Frankfurt, Germany. | Food: Major Diversified | Chief Executive Officer | |
PREMIER FOODS PLC | Food: Specialty/Candy | Director/Board Member | |
HILLEVAX, INC. | Biotechnology | Director/Board Member | |
Kyoto University | College/University | Undergraduate Degree | |
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Chief Executive Officer | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Northeast Ohio Medical University | College/University | Graduate Degree | |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | General Government | Corporate Officer/Principal | |
The White House | General Government | Corporate Officer/Principal | |
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Financial Conglomerates | Corporate Officer/Principal | |
JAPAN TOBACCO, INC. | Tobacco | Corporate Officer/Principal | |
Takeda America Holdings, Inc.
Takeda America Holdings, Inc. Financial ConglomeratesFinance Takeda America Holdings, Inc. is a wholly owned subsidary of Takeda Pharmaceutical Co. Ltd.. It handles cash management & investment activities of the Takeda within the North America Region. The company was founded in 1993 and is headquartered in New York, NY. | Financial Conglomerates | Corporate Officer/Principal | |
George Washington University | College/University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 18 |
Japon | 6 |
France | 2 |
Allemagne | 2 |
Royaume-Uni | 2 |
Sectorielle
Health Technology | 9 |
Consumer Services | 7 |
Consumer Non-Durables | 5 |
Finance | 4 |
Government | 3 |
Opérationnelle
Corporate Officer/Principal | 19 |
Director/Board Member | 11 |
President | 4 |
Chief Executive Officer | 3 |
Doctorate Degree | 3 |
Relations les plus connectées
Insiders | |
---|---|
Shinji Honda | 10 |
Rajeev Venkayya | 9 |
Andrew Plump | 7 |
Alan D MacKenzie | 6 |
Shigenori Ohkawa | 3 |
John Boslego | 2 |
- Bourse
- Insiders
- Tsudoi Miyoshi
- Connexions Sociétés